Newsletter Archive

  1. 04.08.20 -- Inside FDA's AI-Based Established Conditions Pilot 4/8/2020
    04/08/20 BioProcess Online Newsletter
  2. 04.07.20 -- Improve Process Development Efficiency And Outcomes 4/7/2020
    04/07/20 BioProcess Online Newsletter
  3. 04.06.20 -- Assessing The Impact Of COVID-19 On Regulatory Interactions, Inspections, & Audits 4/6/2020
    04/06/20 BioProcess Online Newsletter
  4. 04.02.20 -- What Makes Proactive Clinical Returns Planning So Important? 4/2/2020
    04/02/20 BioProcess Online Newsletter
  5. 04.01.20 -- New FDA Guidance For Clinical Trials Disrupted By COVID-19 4/1/2020
    04/01/20 BioProcess Online Newsletter
  6. 03.31.20 -- Accelerate your biologic manufacturing without wasting drug substance 3/31/2020
    03/31/20 BioProcess Online Newsletter
  7. 03.30.20 -- An Analysis Of FDA's Recently Issued Gene Therapy Guidances 3/30/2020
    03/30/20 BioProcess Online Newsletter
  8. 03.25.20 -- Business Continuity & Coronavirus: Are Pharma Operations At Risk? 3/25/2020
    03/25/20 BioProcess Online Newsletter
  9. 03.24.20 -- Process Improvement Strategies For Biologics 3/24/2020
    03/24/20 BioProcess Online Newsletter
  10. 03.24.20 -- Are You Protecting Your Product And People During ADC And HPAPI Manufacturing? 3/24/2020
    03/24/20 BioProcess Online Newsletter